Federal Court Dismisses PBM Lawsuit Against FTC After Insulin Price Settlements
A federal court has dismissed a lawsuit filed by Express Scripts, CVS Caremark, and Optum Rx against the Federal Trade Commission. The three pharmacy benefit managers had sued the FTC after the agency accused them of inflating insulin costs, but the case is now closed following settlements between the PBMs and regulators. The settlements resolve the FTC's allegations regarding the PBMs' role in insulin pricing practices. The dismissal comes after the parties reached resolution on the underlying insulin pricing dispute.
Medicaid managed care organizations that contract with these three PBMs for pharmacy services need to understand the terms of these insulin pricing settlements, as they may affect rebate structures, formulary management requirements, and insulin cost-sharing obligations for Medicaid beneficiaries.
Pharmacy · Managed Care
You might also like